| Autor: |
Bargiggia G; Microbiology Institute, A.S.S.T. 'Papa Giovanni XXIII', Bergamo, Italy., Ruggeri M; Pediatric Clinic, A.S.S.T. 'Papa Giovanni XXIII', Bergamo, Italy., Ortalli G; Microbiology Institute, A.S.S.T. 'Papa Giovanni XXIII', Bergamo, Italy., Gabrielli S; Parasitology Laboratory, Azienda Policlinico 'Umberto I', Roma, Italy., Rodari P; Infectious Diseases Clinic, A.S.S.T. 'Papa Giovanni XXIII', Bergamo, Italy., D'Antiga L; Pediatric Clinic, A.S.S.T. 'Papa Giovanni XXIII', Bergamo, Italy., Farina C; Microbiology Institute, A.S.S.T. 'Papa Giovanni XXIII', Bergamo, Italy. |
| Abstrakt: |
Chagas disease (CD) is an uncommon disease in Europe. Its epidemiology has changed because of mass migration from Latin America to Europe. Herein we describe a congenital case of CD in a Bolivian newborn in Bergamo, the main city of residence for the Bolivian community in Italy. At delivery, serological analyses evidenced IgG antibodies against Trypanosoma cruzi both in the child and mother, as expected. Hemoscopic analyses on peripheral blood were repeatedly negative during the first months of life. Eventually, thanks to T. cruzi Real Time polymerase chain reaction (RT-PCR) positivity on peripheral blood and development of progressive anemia in the following weeks, congenital Chagas disease was diagnosed and benznidazole-based therapy started. A progressive antibodies' index decrease was observed till negativity (306 days apart). RT-PCR was negative at the end of treatment. Our case is instructive and management of congenital CD is discussed from the perspective of a non-endemic country. |
